[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. The company's lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "fullTimeEmployees": 55, "companyOfficers": [{"maxAge": 1, "name": "Ms. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 35, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 650000, "exercisedValue": 0, "unexercisedValue": 578357}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 48, "title": "President, COO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 660000, "exercisedValue": 0, "unexercisedValue": 103783}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 597500, "exercisedValue": 0, "unexercisedValue": 77109}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 10.15, "open": 10.14, "dayLow": 9.05, "dayHigh": 11.025, "regularMarketPreviousClose": 10.15, "regularMarketOpen": 10.14, "regularMarketDayLow": 9.05, "regularMarketDayHigh": 11.025, "payoutRatio": 0.0, "forwardPE": -6.689441, "volume": 360900, "regularMarketVolume": 360900, "averageVolume": 466734, "averageVolume10days": 527150, "averageDailyVolume10Day": 527150, "bid": 10.67, "ask": 10.94, "bidSize": 2, "askSize": 1, "marketCap": 587215936, "fiftyTwoWeekLow": 8.91, "fiftyTwoWeekHigh": 28.09, "fiftyDayAverage": 12.8416, "twoHundredDayAverage": 17.470242, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 87338552, "profitMargins": 0.0, "floatShares": 28372303, "sharesOutstanding": 54523300, "sharesShort": 5046885, "sharesShortPriorMonth": 4168259, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.092700005, "heldPercentInsiders": 0.00434, "heldPercentInstitutions": 0.85722, "shortRatio": 15.48, "impliedSharesOutstanding": 54523300, "bookValue": 9.035, "priceToBook": 1.192031, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -67995000, "trailingEps": -4.05, "forwardEps": -1.61, "enterpriseToEbitda": -1.061, "52WeekChange": -0.53994024, "SandP52WeekChange": 0.059571505, "quoteType": "EQUITY", "currentPrice": 10.77, "targetHighPrice": 48.0, "targetLowPrice": 31.0, "targetMeanPrice": 39.238, "targetMedianPrice": 37.19, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 489711008, "totalCashPerShare": 8.982, "ebitda": -82333000, "totalDebt": 738000, "quickRatio": 27.221, "currentRatio": 27.934, "debtToEquity": 0.15, "returnOnAssets": -0.13843, "returnOnEquity": -0.19143, "freeCashflow": -53717124, "operatingCashflow": -74751000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1744404493, "regularMarketTime": 1744401600, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 6.1083827, "regularMarketPrice": 10.77, "cryptoTradeable": false, "postMarketPrice": 10.98, "postMarketChange": 0.209999, "regularMarketChange": 0.62000084, "regularMarketDayRange": "9.05 - 11.025", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 466734, "fiftyTwoWeekLowChange": 1.8600006, "fiftyTwoWeekLowChangePercent": 0.20875429, "fiftyTwoWeekRange": "8.91 - 28.09", "fiftyTwoWeekHighChange": -17.32, "fiftyTwoWeekHighChangePercent": -0.61658955, "fiftyTwoWeekChangePercent": -53.994022, "earningsTimestamp": 1743075049, "earningsTimestampStart": 1743075049, "earningsTimestampEnd": 1743075049, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -4.05, "epsForward": -1.61, "epsCurrentYear": -1.6275, "priceEpsCurrentYear": -6.6175117, "fiftyDayAverageChange": -2.0716, "fiftyDayAverageChangePercent": -0.16131945, "twoHundredDayAverageChange": -6.700241, "twoHundredDayAverageChangePercent": -0.3835231, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.3 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 1.94985, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-04-12"}]